应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ABBV 艾伯维公司
盘后交易 10-16 16:01:09 EDT
285.42
+2.02
+0.71%
盘后
285.42
+0.00
0.00%
16:00 EDT
最高
286.64
最低
282.96
成交量
553.96万
今开
283.61
昨收
283.40
日振幅
1.30%
总市值
5,044亿
流通市值
5,032亿
总股本
17.67亿
成交额
15.79亿
换手率
0.31%
流通股本
17.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
AI暴跌下的避风港！大型医药股股价逼近历史新高
华尔街见闻 · 10-16 08:26
AI暴跌下的避风港！大型医药股股价逼近历史新高
异动解读｜艾伯维公司盘中上涨3.13%，Q3营收预期或超市场预期
行情直击 · 10-15 21:55
异动解读｜艾伯维公司盘中上涨3.13%，Q3营收预期或超市场预期
异动解读｜艾伯维公司盘中上涨3.03%，Q3营收预期或超市场预期
行情直击 · 10-14 22:22
异动解读｜艾伯维公司盘中上涨3.03%，Q3营收预期或超市场预期
异动解读｜艾伯维盘中上涨3.06%，FDA授予在研药物两项突破性疗法认定
行情直击 · 10-08
异动解读｜艾伯维盘中上涨3.06%，FDA授予在研药物两项突破性疗法认定
美股深夜，半导体跳水，迈威尔科技跌超2%；中国资产下跌，阿里、百度、霸王茶姬飘绿；医药股逆市走高，礼来涨超2%，艾伯维公司股价创新高
中新经纬 · 10-07
美股深夜，半导体跳水，迈威尔科技跌超2%；中国资产下跌，阿里、百度、霸王茶姬飘绿；医药股逆市走高，礼来涨超2%，艾伯维公司股价创新高
美股生物医药股逆市上扬，安进涨超3%、礼来涨超2%
老虎资讯综合 · 10-07
美股生物医药股逆市上扬，安进涨超3%、礼来涨超2%
艾伯维（ABBV）预计Q3产生2.16亿美元税前研发相关费用 下调EPS指引区间
金吾财讯 · 10-06
艾伯维（ABBV）预计Q3产生2.16亿美元税前研发相关费用 下调EPS指引区间
加拿大丰业银行：将艾伯维(ABBV.US)目标价从280美元上调至320美元。
智通财经 · 10-06
加拿大丰业银行：将艾伯维(ABBV.US)目标价从280美元上调至320美元。
艾伯维宣布，其在研药物ABBV-295在1期临床试验中显示出最高9.8% 的体重减轻效果，表现出“有意义的体重下降”。
智通财经 · 09-30
艾伯维宣布，其在研药物ABBV-295在1期临床试验中显示出最高9.8% 的体重减轻效果，表现出“有意义的体重下降”。
艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准
金吾财讯 · 09-28
艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准
艾伯维（ABBV）Rinvoq获欧盟批准 已拥有11项免疫炎症疾病获批适应症
金吾财讯 · 09-22
艾伯维（ABBV）Rinvoq获欧盟批准 已拥有11项免疫炎症疾病获批适应症
艾伯维宣布欧洲委员会批准Rinvoq®（乌帕替尼）用于治疗活动性多关节型幼年特发性关节炎儿童患者
美股速递 · 09-22
艾伯维宣布欧洲委员会批准Rinvoq®（乌帕替尼）用于治疗活动性多关节型幼年特发性关节炎儿童患者
RNA疗法公司Adarx Pharmaceuticals(ADRX.US)拟赴美IPO募资至多3.72亿美元 制药巨头艾伯维(ABBV.US)已同意投资最高1亿美元
智通财经网 · 09-21
RNA疗法公司Adarx Pharmaceuticals(ADRX.US)拟赴美IPO募资至多3.72亿美元 制药巨头艾伯维(ABBV.US)已同意投资最高1亿美元
艾伯维达成合作，加速免疫学、神经科学与肿瘤学领域小分子药物研发
美股速递 · 09-21
艾伯维达成合作，加速免疫学、神经科学与肿瘤学领域小分子药物研发
艾伯维与Iambic达成合作：前期付款、里程碑付款及分级版税条款揭晓
美股速递 · 09-21
艾伯维与Iambic达成合作：前期付款、里程碑付款及分级版税条款揭晓
艾伯维高管：受医保报销时间影响，Tavapadon美国上市预计将呈“慢热”态势——电话会议实录
美股速递 · 09-15
艾伯维高管：受医保报销时间影响，Tavapadon美国上市预计将呈“慢热”态势——电话会议实录
艾伯维高管：血癌药物Etentamig晚期数据将于9月下旬在国际骨髓瘤学会会议上公布
美股速递 · 09-15
艾伯维高管：血癌药物Etentamig晚期数据将于9月下旬在国际骨髓瘤学会会议上公布
艾伯维高管透露：今年将启动Apogee的Zumilokibart患者入组，目标2030年初上市——电话会议纪要
美股速递 · 09-15
艾伯维高管透露：今年将启动Apogee的Zumilokibart患者入组，目标2030年初上市——电话会议纪要
艾伯维高管：现有产品组合为未来十年强劲增长提供"清晰视野"——电话会议实录
美股速递 · 09-15
艾伯维高管：现有产品组合为未来十年强劲增长提供"清晰视野"——电话会议实录
艾伯维高管：稳健资产负债表与长期成长空间并存，公司可兼顾早期及晚期业务拓展机会——电话会议实录
美股速递 · 09-09
艾伯维高管：稳健资产负债表与长期成长空间并存，公司可兼顾早期及晚期业务拓展机会——电话会议实录
加载更多
公司概况
公司名称：
艾伯维公司
所属市场：
NYSE
上市日期：
--
主营业务：
艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。
发行价格：
--
{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":285.42,"timestamp":1792180800000,"preClose":283.4,"halted":0,"volume":5539581,"hourTrading":{"tag":"盘后","latestPrice":285.42,"preClose":285.42,"latestTime":"16:00 EDT","volume":703022,"amount":200656539.24,"timestamp":1792180852623,"change":0,"changeRate":0,"amplitude":0.000175},"delay":0,"changeRate":0.007127734650670567,"floatShares":1762950764,"shares":1767384632,"eps":3.539701,"marketStatus":"盘后交易","change":2.02,"latestTime":"10-16 16:01:09 EDT","open":283.61,"high":286.64,"low":282.955,"amount":1578966501,"amplitude":0.013003,"askPrice":286,"askSize":10,"bidPrice":285.36,"bidSize":4,"shortable":3,"etf":0,"ttmEps":3.539701,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792195200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":283.4,"dividendRate":0.02393,"preHourTrading":{"tag":"盘前","latestPrice":283.9407,"preClose":283.4,"latestTime":"09:29 EDT","volume":1569,"amount":446601.13278000004,"timestamp":1792157398092,"change":0.5407,"changeRate":0.001908,"amplitude":0.013651},"postHourTrading":{"tag":"盘后","latestPrice":285.42,"preClose":285.42,"latestTime":"16:00 EDT","volume":703022,"amount":200656539.24,"timestamp":1792180852623,"change":0,"changeRate":0,"amplitude":0.000175},"volumeRatio":0.937111,"impliedVol":0.3169,"impliedVolPercentile":0.757},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2675591365","title":"AI暴跌下的避风港！大型医药股股价逼近历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591365","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591365?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:26","pubTimestamp":1792110409,"startTime":"0","endTime":"0","summary":"受AI资本支出担忧影响，资金寻求“确定性溢价”。State Street医疗ETF触及历史新高。礼来、AbbVie均逼近历史最高收盘价，Gilead、Amgen五日分别劲涨7.7%和7.2%。礼来凭借GLP-1主导地位+200亿美元40笔并购持续押注未来；AbbVie核心药Skyrizi皮下注射新剂型数据积极，有望延长专利并带来销售增量。","market":"us","thumbnail":"https://static.tigerbbs.com/12fbc4bd39c3a679cca9696bb3ca466c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/12fbc4bd39c3a679cca9696bb3ca466c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3783744","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNHU","LLY","LLYX","ELIL","CHAT","GILD","AGIX","LLII","AIPO","BK1161","BK1515","ARTY","AMGN","ABBV","ELIS","BK1574","UNHG","UN","UNHW","QTOC","VTHR","UNH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1143515714","title":"异动解读｜艾伯维公司盘中上涨3.13%，Q3营收预期或超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143515714","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143515714?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:55","pubTimestamp":1792072527,"startTime":"0","endTime":"0","summary":"10月15日，艾伯维公司盘中上涨3.13%，报291.1美元/股，成交额2.54亿美元。消息面上，机构最新指出，公司第三季度营收有望超出市场预期，主要由Rinvoq、Skyrizi和Vraylar三款核心疗法驱动，血液肿瘤业务预计大致符合预期，但Humira销售或低于预期。此外，近期多家机构连续上调其目标价至305美元、310美元和320美元，市场对其免疫学与神经科学产品组合增长韧性预期升温。公司将于10月30日披露财报，市场预期每股收益为3.76美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维盘中上涨，三款核心疗法或超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106533582","title":"异动解读｜艾伯维公司盘中上涨3.03%，Q3营收预期或超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1106533582","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106533582?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:22","pubTimestamp":1791987776,"startTime":"0","endTime":"0","summary":"10月14日，艾伯维公司盘中上涨3.03%，报282.67美元/股，成交额1.47亿美元。最新消息显示，机构预计公司第三季度营收有望超出市场预期，主要由Rinvoq、Skyrizi和Vraylar三款核心疗法驱动，血液肿瘤业务预计大致符合预期，但Humira销售或低于预期。在此之前，多家机构已连续上调公司目标价，其中目标价上调至305美元、310美元和320美元，反映市场对其免疫学与神经科学产品组合增长韧性的认可。公司下一次财报将于10月30日披露，市场预期每股收益为3.76美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维盘中上涨，Q3营收预期或超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183400206","title":"异动解读｜艾伯维盘中上涨3.06%，FDA授予在研药物两项突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1183400206","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183400206?lang=zh_cn&edition=full","pubTime":"2026-10-08 00:30","pubTimestamp":1791390623,"startTime":"0","endTime":"0","summary":"10月7日，艾伯维盘中上涨3.06%，报274.86美元/股，成交额4.79亿美元。消息面上，美国食品药品监督管理局授予公司在研药物telisotuzumab adizutecan两项突破性疗法认定，分别用于治疗结直肠癌和非小细胞肺癌，这一监管进展成为盘中股价走强的直接催化剂。突破性疗法认定有助于加速后续临床开发与审评进程，强化了艾伯维在肿瘤学管线的长期价值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维获FDA双突破性疗法，股价应声上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673601697","title":"美股深夜，半导体跳水，迈威尔科技跌超2%；中国资产下跌，阿里、百度、霸王茶姬飘绿；医药股逆市走高，礼来涨超2%，艾伯维公司股价创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673601697","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673601697?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:19","pubTimestamp":1791382754,"startTime":"0","endTime":"0","summary":"北京时间7日晚，美股费城半导体指数跌2%。截至发稿，成分股中，Coherent跌超5%，安森美半导体、迈威尔科技、应用材料等跌超2%。中国资产下跌，纳斯达克中国金龙指数盘初跌约1%。虎虎科技跌超11%，万国数据、有道、新氧跌超3%，霸王茶姬、陆金所控股、阿里巴巴、百度、金山云等飘绿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888963964.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888963964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PPH","LU1868836914.USD","LU1496350502.SGD","WUGI","LU0889565916.HKD","09988","LU0456842615.SGD","SG9999003800.SGD","FDTX","LU1244550577.SGD","LU2756315318.SGD","LU0889566641.SGD","IE00BFSS7M15.SGD","LU1721428933.USD","LU2125909593.SGD","LU2552382215.SGD","LU0225283273.USD","KBAB","LU0823421416.USD","LU1051769294.HKD","LU1119994496.HKD","ARTY","IE00B7SZLL34.SGD","SGXZ31699556.SGD","LU1894683264.USD","LU2324357040.USD","LU1267930573.SGD","LU1868836591.USD","LU0154236417.USD","LU1815336760.USD","IE00BFXG1179.USD","FTXH","COHR","LU1242518931.SGD","CHPS","LU1989772923.USD","AMAT","LU0957808578.USD","PJP","LU2148611432.USD","BK4558","COHX","LU2746668974.SGD","LU1515016050.SGD","LU0426417589.USD","BK4519","LU2360106947.USD","IE00BVYPNW00.USD","IE00BFMHRM44.USD","LU2430703095.HKD","SOX","LU0795875169.SGD","LU2361044865.SGD","IE00BQXX3D17.EUR","LU0949170772.SGD","SG9999017495.SGD","IE00B3PB1722.GBP","LU1032466523.USD","LU0640476718.USD","LU0471298694.HKD","LU2456880835.USD","BK4587","LU2361044949.HKD","BK4502","LU1232071149.USD","GLAM","LU0444971666.USD","BK4532","LU2237443895.HKD","LU0234570918.USD","ABBV","LU1093756168.USD","LU0187121727.USD","LU0310800965.SGD","LU0689472784.USD","QQQA","LU0965509010.AUD","LU2430703178.SGD","COHC","LU0289960550.SGD","IE00B4JS1V06.HKD","LU0061474960.USD","LU1069344957.HKD","04332","SGXZ80539844.SGD","SG9999018865.SGD","LU2361045086.USD","LU1145028129.USD","LU1769817179.HKD","SG9999002232.USD","IE00B5949003.HKD","FXL","BK4592","LU2458330243.SGD","CANC","LU1623119135.USD","LU0545039389.USD","BK4578","LU0868494708.USD","LU1974910355.USD","BK4581","LU0251143458.SGD","LU1769817096.USD","IE00B66KJ199.SGD","LU0348816934.USD","LU1066051498.USD","LU1823568750.SGD","BIDG","BBH","IE0005OL40V9.USD","LU2129689605.HKD","LU0289739699.SGD","LU1291159041.SGD","LU1691799644.USD","LU0918141887.USD","IE00BN29S564.USD","LU0861579265.USD","LU1196500208.SGD","LU2403377893.USD","THNR","IE00B19Z4B17.USD","LU1244550494.USD","LU0072913022.USD","BK4607","IBB","LU2347655156.SGD","LU2602419157.SGD","ONG","LU1989771016.USD","09698","BABO","IE0004086264.USD","LU0162691827.USD","LU1261432733.SGD","SG9999013999.USD","LU1989772840.SGD","LU2087621335.USD","LU2023250843.SGD","LU0651946864.USD","LU2028103732.USD","IE00B7SZL793.SGD","LU1732800096.USD","IE00BQXX3C00.GBP","LU1046422090.SGD","LU1169590202.USD","LU1854104046.USD","VHT","LU0882574055.USD","LU0347712357.USD","LU0210528500.USD","TINY","SG9999014898.SGD","LU1043141123.HKD","LU0726765562.USD","LU1571399168.USD","BK4610","IE00BMPRXR70.SGD","LU0320765992.SGD","JDOC","LU1115378108.SGD","LU1048596156.SGD","BK4139","LU0823434740.USD","LU2242652126.USD","LU1236620750.USD","ELIS","LU1868837300.USD","LU2290526834.HKD","RDVI","CLIX","EPAI","LU0079474960.USD","LU0821914370.USD","AGNG","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4588","LU2168564495.EUR","LU1718418525.SGD","LU0511384066.AUD","LU1868836757.USD","ALBmain","LU1303367103.USD","LU0203347892.USD","COHH","LU0094547139.USD","LU0880133367.SGD","SG9999014906.USD","LU0128525689.USD","LU2213496289.HKD","LU0918141705.HKD","BK4141","LU0067412154.USD","LU1585245621.USD","LU2592432038.USD","LU2089284900.SGD","LU1929549753.HKD","LU0738911758.USD","LU0348723411.USD","IE00BKDWB100.SGD","LU1267930227.SGD","LU0061475181.USD","ON","LU1989764664.SGD","LU0820561909.HKD","LU0310800379.SGD","LU0029864427.USD","IE00BSNM7G36.USD","LU2430703251.USD","LU1032955483.USD","LU2112291526.USD","BABU","TRUH","LU2237443622.USD","BK4533","BK4504","LU0170899867.USD","LU0266013472.USD","LU0323591593.USD","LU0053666078.USD","BK4147","SG9999015952.SGD","BK4526","LU1935042991.SGD","FOTO","GB00BDT5M118.USD","XNTK","BK4007","LU1023059063.AUD","LU2168564222.USD","LU1803068979.SGD","IE000BZT7R73.USD","BK4605","LU0320765646.SGD","LU2357305700.SGD","LU0823421333.USD","LU0957791311.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU2089984988.USD","BK4539","FTXL","LU1506573853.SGD","LU1989764748.USD","LU2552382132.HKD","BIDU","DRAG","LU0786609619.USD","BK4148","LU2473716301.USD","LU1037948897.HKD","LU2896262040.SGD","BK4575","IE00B1XK9C88.USD","LU2458330169.SGD","BK4612","LU1023057109.AUD","LU0070217475.USD","SMHX","LU2237443465.HKD","LU2505996681.GBP","LU0127658192.USD","RDVY","LU2322448957.HKD","BK4567","LU0109392836.USD","BK4602","TBXU","LU1496350171.SGD","LU0471298777.SGD","IE0034235303.USD","LU1914381329.SGD","IE000SO60NU8.SGD","LU1066053197.SGD","LU1430594728.SGD","SG9999014914.USD","BK4599","IE00BK4W5L77.USD","LU1057294990.SGD","IE00BKVL7J92.USD","LU1674673691.USD","AMGN","SGXZ99366536.SGD","IE00B2B36J28.USD","LU0545562505.USD","LU1934455277.USD","IE0004091025.USD","LU2543165471.USD","LU1815333072.USD","ELIL","LU1282648689.USD","LU0124676726.USD","GDOC","LU1814569148.SGD","LU0354030438.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","ONX","BK4518","LLYX","LU0056508442.USD","LU0965508806.USD","BK4548","LU1221951046.USD","LU0106261372.USD","LU0072461881.USD","LU1037948541.HKD","LU1043141396.HKD","BK4563","LU0820561818.USD","LU2461242641.AUD","LU1267930813.SGD","LU1003077747.HKD","LU2264538146.SGD","IE00BKPKM429.USD","LU0238689110.USD","LU1267930490.SGD","LU1221951129.SGD","LU1868837136.USD","EGGY","LU1316542783.SGD","LU2272731600.USD","LU2087625088.SGD","LU0122379950.USD","LU0345770308.USD","IE0000B7K699.USD","LU0158827781.USD","LU2750360997.AUD","SG9999001176.SGD","IE00BMPRXN33.USD","LU0106959298.USD","LU0203345920.USD","LU1153585028.USD","BBYY","LU0345769128.USD","LU0501845795.SGD","LU0964807845.USD","LU1688375341.USD","LU2129689514.USD","LU2098885051.SGD","LU1917777945.USD","LU2471134952.CNY","LU2298322129.HKD","LU0912757837.SGD","BK4543","LU2322448791.USD","LU0203202063.USD","LU0642271901.SGD","LU2244417387.USD","LU2931357623.SGD","IE00BJLML261.HKD","BMED","LU1074936037.SGD","LU0651947912.USD","LU0354030511.USD","CURE","LU2471134796.USD","LU1280957306.USD","SG9999015945.SGD","BK4505","LU0174119429.USD","LU0211328371.USD","LU1323610961.USD","LU1670628061.USD","TDV","LU2237443382.USD","IE000F7OJYX1.SGD","SHOC","IE00BFSS8Q28.SGD","LU2417539215.USD","BK4565","LU0359202008.SGD","LU0792757196.USD","BK4209","LU0708994859.HKD","IE000WAW04H5.SGD","LU1048588211.SGD","ONLN","LU2236285917.USD","LU2433249047.HKD","LU0198837287.USD","BK4574","IE00BJJMRX11.SGD","LU0128525929.USD","LU0943347566.SGD","LU2063271972.USD","BABA","LLII","LU1861220033.SGD","LU0820562030.AUD","LU0426412945.USD","LU0787776722.HKD","LU1169589451.USD","LU1934455863.HKD","BABW","SGXZ81514606.USD","BK4534","SG9999011175.SGD","IE00B775H168.HKD","LU1066051225.USD","LU2462591350.SGD","IE00B7KXQ091.USD","LU0175139822.USD","LU2211814178.USD","SG9999002224.SGD","LU1983260115.SGD","LU1804176565.USD","LU0965509101.SGD","LU2272731782.SGD","BK4157","LU0868494617.USD","IE00B0JY6N72.USD","IE0004445015.USD","LU0859254822.USD","IE00BFTCPJ56.SGD","APMI","LU0724618433.USD","LU1989763005.USD","LU2089283258.USD","KBDU","LU0348814723.USD","LU0882574139.USD","LU0211327993.USD","COHQ","SG9999015978.USD","LU2271345857.HKD","LU0276348264.USD","LU1127390331.HKD","IE0009355771.USD","IE0009356076.USD","LU2023250504.SGD","BIB","LU0256863811.USD","LU1732799900.SGD","LU0274383776.USD","IBBQ","LU0289739343.SGD","LU2357627491.SGD","LU1992135399.USD","LU0385154629.USD","OZEM","LU0708995401.HKD","IE0002141913.USD","BK4514","LU0061474705.USD","RXL","LU2471134523.USD","LU0432979614.USD","SG9999001176.USD","BABX","BK4550","IE00BLSP4239.USD","ILDR","LU1992135472.HKD","BK4535","LU0173614495.USD","LU1008478684.HKD","LU2168564065.EUR","IE00BN8TJ469.HKD","LU0640798160.USD","04336","LU2413666426.HKD","LU1989773731.SGD","09888","LU0210536198.USD","LU2468319806.SGD","BK4554","LU0072462343.USD","LU2211815571.USD","LU2272731865.HKD","WDNA","QQQG","BK4515","LU0124384867.USD","LU0979878070.USD","LU1978683503.SGD","LU0672654240.SGD","LU1228905540.USD","LU0985320562.USD","BK4512","IE00B1BXHZ80.USD","LU0316494557.USD","SG9999018857.SGD","LU0795875086.SGD","BABC","BK4552","DTCR","IE00BZ199S13.USD","LU2360107325.USD","SG9999000418.SGD","SOXY","LU0047713382.USD","LU0287142896.SGD","BK4604","LU1551013342.USD","LU2360107168.USD","LU1061106388.HKD","LU0345769631.USD","BK4524","LU0689626769.HKD","LU2106854487.HKD","BK4503","AMA","IXJ","LU1880383366.USD","AMAU","SPRX","MEDX","TMED","IE00BD6J9T35.USD","IE00BLSP4452.SGD","LU2491050154.USD","LU0661504455.SGD","LU2491049909.HKD","LU1066051811.HKD","LU1720051017.SGD","BK4116","IE00B4R5TH58.HKD","IE00BWXC8680.SGD","LU0466842654.USD","BK4579","LU1105468828.SGD","LU2108987350.USD","LU0797268264.HKD","LU0109391861.USD","LU0052756011.USD","LU1894683348.USD","LU0353189680.USD","BK4077","SG9999015986.USD","LU0320765059.SGD","LU0348766576.USD","LU1244550221.USD","LU1988902786.USD","SG9999014880.SGD","LU2746668461.USD","AIS","LU0097036916.USD","LU1839511570.USD","BK4566","IHE","IE00BZ1G4Q59.USD","LU1923622614.USD","LU2023251221.USD","LU0353189763.USD","IE00BF5LJ272.USD","LU1093756325.SGD","LU0328353924.USD","FAI","LU2265009873.SGD","LU0006306889.USD","LU2247934214.USD","LU0158827948.USD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","BK4531","LU1035775433.USD","LU2237438978.USD","LU2237443549.SGD","LU1642822529.SGD","AIFD","XLV","IE00BK4W5M84.HKD","JNJ","LU1720051108.HKD","LU1934455194.USD","BK4220","LU1861215975.USD","LU1670627923.USD","IE00BVYPNV92.GBP","LU0109394709.USD","LU2129689431.USD","FHLC","IE00B42XCP33.USD","SG9999001440.SGD","LU1084165304.USD","LU0096362180.USD","LU1152091168.USD","LU1548497426.USD","BK4122","LU1051768304.USD","LU0942090050.USD","IE0002270589.USD","SOXQ","IE0031619046.USD","IE00BGHQF631.EUR","BK4614","LU2168564149.EUR","SGXZ51526630.SGD","LU0395794307.EUR","LU0476273544.USD","LU0444973449.USD","LU2750360641.GBP","LU1228905037.USD","BK4527","LU0114720955.EUR","LU1852331112.SGD","LU2413666699.HKD","LU2023250330.USD","LU2552382058.USD","BK4568","LU0289961442.SGD","LU1778281490.HKD","LU0011850046.USD","BK4516","LU0057025933.USD","LU1236620834.HKD","IYH","LU1064131342.USD","SG9999001424.SGD","LLYZ","LU1162221912.USD","LU0310799852.SGD","LU0417517546.SGD","LU1861219969.SGD","LU2089985449.USD","LU1046421795.USD","IE00BBT3K403.USD","SMH","GTEK","LU1152091754.HKD","LU2242646821.SGD","LU1674673428.USD","LU0256863902.USD","MRVX","LLY","LU1242518857.USD","IE000MB6IJN5.SGD","MEDI","MRVU","LU0098860793.USD","LU1629891620.HKD","LU1712237335.SGD","LU1551013425.SGD","LU0823416689.USD","LU0069063385.USD","LU0058720904.USD","CHA","LU0965509283.SGD","LU0348767384.USD","DRGN","LU1267930730.SGD","LU1121112475.USD","BK4583","GILD","MRVL","LU2471134879.HKD","LU2133065610.SGD","LU0472753341.HKD","LU1059921491.USD","LU2462157665.USD","LU2505996509.AUD","BK4559","GDS","LU1235294995.USD","LU2487616109.SGD","IE00BDGV0183.EUR","LU2491050071.SGD","LU0133085943.USD","LU1366192091.USD","LU2756315664.SGD","HRTS","LU1854103824.USD","IE0001KFT4U8.USD","LU1861214812.USD","IE00BMPRXQ63.HKD","LU0823434583.USD","LU0553294199.USD","LU2125909247.SGD","LUMA","LU0345770993.USD","LU0683600562.USD","BK4585","LU0359201612.USD","LU2237443978.SGD","LU2111349929.HKD","LU0081259029.USD","IE00BQXX3F31.USD","MVLL","LU0234572021.USD","MHIP","LU2168563687.JPY","LU0994945656.USD","IE0004445239.USD","LU1979441026.SGD","PSI","BK4538","PBE","LU2347655073.USD","IE00B3T34201.USD","LU0456855351.SGD","LU0203201768.USD","LU0889565833.HKD","BK4529","LU2226246903.HKD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152649064","title":"美股生物医药股逆市上扬，安进涨超3%、礼来涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152649064","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152649064?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:06","pubTimestamp":1791382000,"startTime":"0","endTime":"0","summary":"10月7日，美股生物医药股逆市上扬，$安进(AMGN)$涨超3%，$吉利德科学(GILD)$涨近3%，$礼来(LLY)$、$强生(JNJ)$、$艾伯维公司(ABBV)$涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0640476718.USD","TRUH","SGXZ81514606.USD","IE00B775H168.HKD","LU2237443465.HKD","SGXZ99366536.SGD","SGXZ80539844.SGD","LU1066051811.HKD","LU0203345920.USD","LU1804176565.USD","IE00B1XK9C88.USD","LU1236620750.USD","ELIS","LU0385154629.USD","LU0162691827.USD","LU2361044949.HKD","SGXZ51526630.SGD","LU0234572021.USD","LU1221951046.USD","LU1430594728.SGD","LU0053666078.USD","LU0320765646.SGD","LU2264538146.SGD","LU0792757196.USD","LU2487616109.SGD","LU1894683264.USD","LU0823416689.USD","BK4534","LU1037948897.HKD","LU1066051225.USD","LU2242652126.USD","LU1720051108.HKD","LU0316494557.USD","BK4592","LU0057025933.USD","LU2602419157.SGD","LU0912757837.SGD","LU0965509010.AUD","LU1868836914.USD","IE000F7OJYX1.SGD","LU2125909593.SGD","THNR","LLYZ","LU1196500208.SGD","LU0345770308.USD","BK4599","IE00B7KXQ091.USD","LU0256863902.USD","LU0882574139.USD","LU2089984988.USD","LU0738911758.USD","LU2028103732.USD","LU0128525929.USD","LU1069344957.HKD","LU0323591593.USD","LU2468319806.SGD","LU0225283273.USD","LU1929549753.HKD","LU1035775433.USD","LU2271345857.HKD","LU1670627923.USD","LU1366192091.USD","LU2403377893.USD","LU2357627491.SGD","IE00BK4W5M84.HKD","LU0109394709.USD","LU0203202063.USD","LU2023250330.USD","LU2237443549.SGD","SG9999003800.SGD","LU1720051017.SGD","LU1718418525.SGD","LU0072461881.USD","LU2125909247.SGD","LU1267930490.SGD","LU2471134523.USD","IE000BZT7R73.USD","LU2456880835.USD","LU2237438978.USD","IE00BVYPNV92.GBP","LU0097036916.USD","LU1244550494.USD","IE0002141913.USD","SG9999017495.SGD","BBH","LU2023250504.SGD","LU0096364046.USD","LU1674673428.USD","LU2213496289.HKD","IE0004445239.USD","LU0061475181.USD","LU2236285917.USD","LU0545562505.USD","IE00BJJMRY28.SGD","IYH","LU1043141123.HKD","LU1712237335.SGD","LU1228905540.USD","JDOC","LU1496350502.SGD","LU0210528500.USD","LU0661504455.SGD","LU1548497426.USD","IE00BWXC8680.SGD","LU1236620834.HKD","IE00BBT3K403.USD","LU2491049909.HKD","LU0109391861.USD","IBB","LU0708994859.HKD","LU0965509101.SGD","IE000MB6IJN5.SGD","SG9999013999.USD","IE0034235303.USD","IE00BJT1NW94.SGD","LU0820561909.HKD","MHIP","LU2063271972.USD","ILDR","LU0069063385.USD","BK4583","SGXZ31699556.SGD","LU0820562030.AUD","LU1691799644.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU1674673691.USD","LU1093756325.SGD","BK4139","BK4550","LU1551013342.USD","BK4533","IE00BN29S564.USD","LU0889565916.HKD","LU1323610961.USD","LU1057294990.SGD","LU0058720904.USD","LU1585245621.USD","LU2089284900.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU0432979614.USD","BK4532","IE00BGHQF631.EUR","LU0310799852.SGD","IE00BK4W5L77.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU2347655156.SGD","LU1629891620.HKD","CURE","LU1043141396.HKD","LU1935042991.SGD","LU0354030438.USD","LU0006306889.USD","LU1732799900.SGD","SG9999001440.SGD","LU0882574055.USD","LU1934455863.HKD","LU0174119429.USD","LU1267930730.SGD","LU1221951129.SGD","LU0133085943.USD","LU1261432733.SGD","LU1551013425.SGD","LU0158827948.USD","LU0672654240.SGD","LU2129689431.USD","LU1979441026.SGD","LU1839511570.USD","LU2108987350.USD","LU1032955483.USD","GB00BDT5M118.USD","LU0795875169.SGD","FHLC","LU1894683348.USD","LU1121112475.USD","LU2357305700.SGD","161726","IE00BN8TJ469.HKD","LU0868494708.USD","LU2756315664.SGD","IHE","IE00BVYPNW00.USD","IE00BJLML261.HKD","LU0106261372.USD","LU0114720955.EUR","LU1066053197.SGD","LU0238689110.USD","LU1059921491.USD","LU0079474960.USD","LU2433249047.HKD","SG9999002224.SGD","LU0320765992.SGD","IE00B4JS1V06.HKD","BK4578","LU2746668974.SGD","LU0417517546.SGD","LU1923622614.USD","XBI","HRTS","LU0345769631.USD","LU2112291526.USD","SG9999002232.USD","LU2242646821.SGD","LU1670628061.USD","LU1244550221.USD","LU1917777945.USD","LU0289961442.SGD","LU1868837300.USD","LU2462591350.SGD","IE00BFSS8Q28.SGD","LU1989772923.USD","LU1291159041.SGD","LU1228905037.USD","LU0395794307.EUR","BK4568","LU0122379950.USD","LU2237443895.HKD","LU0211327993.USD","LU0098860793.USD","LU2756315318.SGD","RXL","LU0708995401.HKD","SG9999001176.SGD","LU0456855351.SGD","LU0310800379.SGD","LU0786609619.USD","LU0094547139.USD","SG9999014914.USD","BK4585","LU2237443622.USD","SG9999015952.SGD","BK4559","LU0889566641.SGD","LU0158827781.USD","LU0170899867.USD","CANC","LU2471134796.USD","LU1868836757.USD","PJP","LU1267930813.SGD","LU2133065610.SGD","IE0004445015.USD","LU0426417589.USD","LU0471298694.HKD","LU1280957306.USD","LU1778281490.HKD","LU2089283258.USD","LU0211328371.USD","IE00B3PB1722.GBP","LU1914381329.SGD","LU2430703178.SGD","LU0426412945.USD","LU1145028129.USD","LU0949170772.SGD","PBE","TBXU","LU2552382058.USD","LU2168564149.EUR","LU2750360641.GBP","LU0964807845.USD","LU0553294199.USD","LU2491050154.USD","LU0070217475.USD","IE00B19Z3581.USD","LU0466842654.USD","LU2462157665.USD","IE00BJJMRX11.SGD","LU2168564222.USD","LU0198837287.USD","SG9999001176.USD","IBBQ","LU1074936037.SGD","LLY","LU2237443978.SGD","LU2471134952.CNY","LU1267930573.SGD","IE00BKDWB100.SGD","BK4566","LU2324357040.USD","VHT","OZEM","LU2491050071.SGD","IE00B42XCP33.USD","MEDX","SG9999015986.USD","PPH","LU1988902786.USD","LU1127390331.HKD","IE0005OL40V9.USD","ELIL","LU0726765562.USD","IE00BLSP4452.SGD","SG9999015945.SGD","IE00BKVL7J92.USD","LU1244550577.SGD","LU0787776722.HKD","LU1868836591.USD","LU1989772840.SGD","LU0965509283.SGD","LU2417539215.USD","LU0965508806.USD","LU2211815571.USD","LU0823434583.USD","IXJ","LU0868494617.USD","LU0545039389.USD","LU1023059063.AUD","LU2461242641.AUD","LU2265009873.SGD","LU0210536198.USD","MEDI","LU2087625088.SGD","BK4007","LU0345770993.USD","LU1506573853.SGD","TMED","LU1032466523.USD","IE00B1BXHZ80.USD","GLAM","LU1934455277.USD","IE00BSNM7G36.USD","LU0942090050.USD","LLII","LU0256863811.USD","IE00BFSS7M15.SGD","LU0859254822.USD","IE000SO60NU8.SGD","IE00BFXG1179.USD","IE0009355771.USD","LU1868837136.USD","IE0000B7K699.USD","LU0353189680.USD","LU2106854487.HKD","IE00BLSP4239.USD","IE0002270589.USD","BK4588","LU1989771016.USD","LU2168563687.JPY","LU0234570918.USD","LU1571399168.USD","LU2505996509.AUD","LU1974910355.USD","LU2168564495.EUR","LU2430703095.HKD","LU1496350171.SGD","LU1037948541.HKD","IE0001KFT4U8.USD","LU0471298777.SGD","LU2129689514.USD","IE00B3T34201.USD","LU2360106947.USD","LU0820561818.USD","LU0354030511.USD","LU2361045086.USD","AMGN","LU1732800096.USD","XLV","LU1093756168.USD","LU0203201768.USD","LLYX","LU2129689605.HKD","LU2430703251.USD","SG9999014898.SGD","ABBV","LU0985320562.USD","LU2168564065.EUR","IE00BKPKM429.USD","FTXH","BK4504","LU2361044865.SGD","LU0472753341.HKD","JNJ","BMED","SG9999015978.USD","LU0320765059.SGD","LU1003077747.HKD","SGXZ57979304.SGD","BK4516","LU2505996681.GBP","LU2237443382.USD","GILD","IE00B2B36J28.USD","LU2552382132.HKD","IE00BZ1G4Q59.USD","IE00BDGV0183.EUR","LU0345769128.USD","SG9999018857.SGD","IE00B7SZLL34.SGD","AGNG","LU2087621335.USD","LU2347655073.USD","LU2592432038.USD","WDNA","LU1162221912.USD","LU1983299246.USD","LU2023251221.USD","LU0266013472.USD","SG9999014906.USD","LU1814569148.SGD","LU1934455194.USD","SG9999018865.SGD","IE00BFTCPJ56.SGD","GDOC","LU1232071149.USD","SG9999014880.SGD","LU0689472784.USD","LU0203347892.USD","IE000WAW04H5.SGD","LU2552382215.SGD","LU2471134879.HKD","BK4581","LU0124676726.USD","LU2750360997.AUD","LU1623119135.USD","LU0353189763.USD","LU0823434740.USD","LU0943347566.SGD","LU2111349929.HKD","IE000M9KFDE8.USD","LU0683600562.USD","LU1064131342.USD","LU0289739343.SGD","LU0795875086.SGD","BIB","LU0689626769.HKD","LU0029864427.USD","LU0861579265.USD","LU0994945656.USD","LU2746668461.USD","LU0511384066.AUD","LU2896262040.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673030343","title":"艾伯维（ABBV）预计Q3产生2.16亿美元税前研发相关费用 下调EPS指引区间","url":"https://stock-news.laohu8.com/highlight/detail?id=2673030343","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673030343?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:24","pubTimestamp":1791278689,"startTime":"0","endTime":"0","summary":"金吾财讯 | 艾伯维（ABBV）披露，其三季度财报或将计入税前2.16亿美元的收购取得的在研技术（IPR&D）及里程碑费用。受此影响，公司GAAP及非GAAP摊薄每股收益将承压0.11美元。计入该笔费用后，艾伯维全年调整后摊薄每股收益预期为13.76-13.96美元（市场一致预期14.01美元）；三季度调整后摊薄每股收益预期区间3.73-3.77美元（市场一致预期3.84美元）。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306862","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673037400","title":"加拿大丰业银行：将艾伯维(ABBV.US)目标价从280美元上调至320美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673037400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673037400?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:09","pubTimestamp":1791277753,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443382.USD","FHLC","BK4559","BNS","LU1037948541.HKD","LU1929549753.HKD","FTXH","MEDX","ABBV","IXJ","PJP","UDN","JDOC","LU1839511570.USD","LU1551013425.SGD","LU0472753341.HKD","GLAM","IE000WAW04H5.SGD","IE00B19Z3581.USD","LU0289961442.SGD","LU2129689605.HKD","LU1061106388.HKD","BK4550","LU0726765562.USD","LU2089284900.SGD","LU0708994859.HKD","AGNG","PPH","XLV","LU0203345920.USD","LU0256863902.USD","LU1934455277.USD","LU0256863811.USD","IE00BDGV0183.EUR","LU0211327993.USD","LU1732799900.SGD","RXL","LU1023059063.AUD","LU0553294199.USD","VHT","LU0511384066.AUD","IE00BLSP4239.USD","IYH","LU1093756325.SGD","TRUH","SG9999015986.USD","UUP","LU0234572021.USD","LU2112291526.USD","LU1236620750.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671083212","title":"艾伯维宣布，其在研药物ABBV-295在1期临床试验中显示出最高9.8% 的体重减轻效果，表现出“有意义的体重下降”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2671083212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671083212?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:52","pubTimestamp":1790761977,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","BMED","VHT","LU0256863811.USD","IE00B42XCP33.USD","IYH","SG9999015978.USD","LU1244550221.USD","LU0256863902.USD","IXJ","LU1989772840.SGD","ABBV","GLAM","LU0114720955.EUR","LU1244550577.SGD","SG9999015945.SGD","IBBQ","IE000SO60NU8.SGD","AGNG","LU0289739699.SGD","XLV","IE00B3PB1722.GBP","MDTX","SG9999015952.SGD","LU1023059063.AUD","LU2237443978.SGD","SG9999011175.SGD","JDOC","PPH","LU0320765646.SGD","LU2112291526.USD","LU1720051017.SGD","LU0985320562.USD","FTXH","PSYK","LU1732800096.USD","RXL","IE00BBT3K403.USD","LU2433249047.HKD","LU2237443465.HKD","FHLC","TRUH","LU0395794307.EUR","LU0823416689.USD","LU1670627923.USD","LU0859254822.USD","LU0211327993.USD","LU0943347566.SGD","IBBJ","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670578258","title":"艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670578258","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670578258?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:15","pubTimestamp":1790601343,"startTime":"0","endTime":"0","summary":"此次获批基于成功的3期TEMPO临床项目。艾伯维官方表示，计划于2026年10月正式将Juvmo投放美国市场，供帕金森病患者使用。据介绍，该药是艾伯维此前斥资87亿美元收购Cerevel Therapeutics公司后迎来的首个重大研发成果落地，进一步夯实了其在神经科学领域的全球领先地位。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306564","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","IE0009355771.USD","LU0289961442.SGD","AGNG","LU0203347892.USD","IE00B19Z3B42.SGD","LU1720051017.SGD","LU0128525929.USD","BK4581","LU1496350502.SGD","LU1244550577.SGD","JDOC","LU1839511570.USD","LU1037948897.HKD","LU1929549753.HKD","FHLC","LU1934455863.HKD","PJP","SG9999001440.SGD","ABBV","IYH","LU1934455277.USD","PPH","RXL","LU0203345920.USD","XLV","MEDX","FTXH","LU0942090050.USD","LU1267930573.SGD","LU1720051108.HKD","LU2125909247.SGD","LU1093756168.USD","LU1718418525.SGD","VHT","LU0882574055.USD","LABU","LU1989772923.USD","IBRN","IPOS","BK4533","IE0002141913.USD","LU2087621335.USD","LU0738911758.USD","TRUH","LU0124676726.USD","IE00BSNM7G36.USD","LU0289739343.SGD","LU0211327993.USD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669117143","title":"艾伯维（ABBV）Rinvoq获欧盟批准 已拥有11项免疫炎症疾病获批适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2669117143","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669117143?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:44","pubTimestamp":1790066647,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据外媒报道，艾伯维（ABBV）周二宣布，Rinvoq获欧盟批准，用于治疗对一种或多种改善病情抗风湿药（DMARD）应答不足或不耐受的2岁及以上活动性多关节型幼年特发性关节炎患者。艾伯维表示，Rinvoq可单药使用，也可与甲氨蝶呤联合用药。本次获批依据开放标签Ⅰ期SELECT-YOUTH研究以及成人类风湿关节炎的相关临床数据，同时该药物全新口服溶液剂型也获批用于pJIA患者。此外，Rinvoq在欧盟已获批11项针对各类免疫介导性炎症性疾病的适应症。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306308","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LU0122379950.USD","LU0708994859.HKD","FTXH","VHT","ABBV","BK4559","LU0868494708.USD","LU1718418525.SGD","IE0004445239.USD","LU0203345920.USD","MEDX","FESXmain","IE00BJJMRZ35.SGD","LU0985320562.USD","LU1061106388.HKD","LU0823416689.USD","IE00BN8TJ469.HKD","LU0942090050.USD","LU0545039389.USD","IE00BBT3K403.USD","JDOC","IXJ","IE0009355771.USD","PPH","IE000SO60NU8.SGD","LU1551013425.SGD","FSXEmain","LU1162221912.USD","BK4585","LU0820561818.USD","LU1989772840.SGD","GLAM","LU2023251221.USD","TRUH","XLV","IE00B19Z3B42.SGD","IE00BVYPNW00.USD","LU0128525929.USD","RXL","LU0395794307.EUR","FHLC","LU0661504455.SGD","IYH","PJP","LU0029864427.USD","SG9999015978.USD","LU1923622614.USD","LU2237443622.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143024609","title":"艾伯维宣布欧洲委员会批准Rinvoq®（乌帕替尼）用于治疗活动性多关节型幼年特发性关节炎儿童患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1143024609","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143024609?lang=zh_cn&edition=full","pubTime":"2026-09-22 14:01","pubTimestamp":1790056882,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）今日正式宣布，欧洲委员会已批准其重磅药物Rinvoq®（通用名：乌帕替尼，Upadacitinib）扩大适应症范围，用于治疗患有活动性多关节型幼年特发性关节炎的儿童患者。这一决定标志着该药物在儿科风湿病学领域的又一重大突破。多关节型幼年特发性关节炎是一种罕见但严重的慢性自身免疫性疾病，主要影响儿童，可导致关节疼痛、肿胀乃至永久性关节损伤，长期以来一直缺乏充足且有效的治疗选择。此次获批，无疑为这些低龄患者及其家庭带来了新的希望与曙光。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU2237443465.HKD","FTXH","LU2129689605.HKD","IE00B3PB1722.GBP","IE00BGHQF631.EUR","LU0432979614.USD","SG9999015986.USD","LU1929549753.HKD","IE00B19Z3581.USD","IE000SO60NU8.SGD","IE0000B7K699.USD","LU0234570918.USD","LU2089984988.USD","LU1057294990.SGD","LU1585245621.USD","LU0203345920.USD","LU0965509283.SGD","LU2347655073.USD","IE0004445239.USD","LU0472753341.HKD","IE00BN8TJ469.HKD","LU0553294199.USD","LU0912757837.SGD","IE000F7OJYX1.SGD","LU2129689514.USD","LU1923622614.USD","LU1989772840.SGD","SG9999011175.SGD","LU0122379950.USD","LU0211327993.USD","LU0861579265.USD","LU0868494708.USD","LU0965509101.SGD","LU1496350171.SGD","LU2125909247.SGD","LU1037948897.HKD","LU1670628061.USD","IE000WAW04H5.SGD","LU0708994859.HKD","LU1093756325.SGD","LU0820561818.USD","LU0545039389.USD","LU0985320562.USD","LU1244550577.SGD","LU0203347892.USD","LU0965508806.USD","LU0198837287.USD","IE00BVYPNV92.GBP","LU2089284900.SGD","LU1496350502.SGD","LU1551013425.SGD","LU1732799900.SGD","LU2237443895.HKD","LU1236620834.HKD","LU1732800096.USD","LU0738911758.USD","BK4566","LU0942090050.USD","AGNG","BK4581","PJP","SG9999003800.SGD","LU2023251221.USD","LU2133065610.SGD","LU1291159041.SGD","LU0965509010.AUD","LU1934455863.HKD","LU1267930490.SGD","IE0002141913.USD","LU1934455277.USD","LU0395794307.EUR","LU2468319806.SGD","LU2357627491.SGD","IXJ","IE0009355771.USD","LU1061106388.HKD","LU0795875086.SGD","BK4559","LU1244550494.USD","LU1670627923.USD","LU2237443549.SGD","BK4534","BK4139","IE00BVYPNW00.USD","LU0289961442.SGD","VHT","IE00BSNM7G36.USD","PPH","ABBV","IE00BLSP4239.USD","LU1551013342.USD","LU0256863811.USD","LU2237443382.USD","TRUH","LU0689472784.USD","LU1720051017.SGD","LU1989771016.USD","LU0124676726.USD","LU1720051108.HKD","LU0029864427.USD","LU0211328371.USD","FHLC","LU0128525929.USD","LU1037948541.HKD","LU2129689431.USD","LU0868494617.USD","LU0114720955.EUR","SG9999015945.SGD","LU1244550221.USD","LU0417517546.SGD","MEDX","XLV","LU0456855351.SGD","LU0859254822.USD","LU0234572021.USD","IE0002270589.USD","LU0256863902.USD","LU1839511570.USD","IE00BBT3K403.USD","IE00BDGV0183.EUR","LU0058720904.USD","LU0098860793.USD","LU1548497426.USD","LU0057025933.USD","LU0310799852.SGD","LU2347655156.SGD","LU0882574055.USD","LU1074936037.SGD","IYH","IE000BZT7R73.USD","LU2433249047.HKD","LU0069063385.USD","LU1267930573.SGD","LU2087621335.USD","IE000MB6IJN5.SGD","LU0170899867.USD","LU2237443622.USD","LU0823416689.USD","LU1430594728.SGD","LU1983299246.USD","JDOC","BK4585","LU0949170772.SGD","LU2125909593.SGD","RXL","LU1023059063.AUD","LU1934455194.USD","LU1093756168.USD","LU0820561909.HKD","IE00B42XCP33.USD","SG9999015978.USD","LU1718418525.SGD","SG9999001440.SGD","LU0320765646.SGD","LU1003077747.HKD","LU1989772923.USD","SG9999015952.SGD","GLAM","LU0511384066.AUD","LU0795875169.SGD","LU0158827948.USD","IE00B4R5TH58.HKD","LU2357305700.SGD","LU0661504455.SGD","LU0689626769.HKD","LU1236620750.USD","IE00BJJMRZ35.SGD","LU0289739343.SGD","LU2237443978.SGD","BK4550","LU0943347566.SGD","IE00B19Z3B42.SGD","BK4533","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1162221912.USD","LU2089283258.USD","LU2112291526.USD","BK4588","LU0310800379.SGD","LU0726765562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669628161","title":"RNA疗法公司Adarx Pharmaceuticals(ADRX.US)拟赴美IPO募资至多3.72亿美元 制药巨头艾伯维(ABBV.US)已同意投资最高1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669628161","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669628161?lang=zh_cn&edition=full","pubTime":"2026-09-21 23:58","pubTimestamp":1790006296,"startTime":"0","endTime":"0","summary":"处于临床后期开发阶段的RNA疗法公司Adarx Pharmaceuticals计划通过美国首次公开募股(IPO)筹集至多3.719亿美元资金","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260922/20260922000340_53804.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260922/20260922000340_53804.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["KCE","IE00B19Z3581.USD","LU1670628061.USD","LU0170899867.USD","LU0965509101.SGD","PPH","IE000WAW04H5.SGD","VHT","LU2089984988.USD","LU0395794307.EUR","LU1093756168.USD","BK4581","LU0965508806.USD","LU0726765562.USD","LU0795875169.SGD","LU2023251221.USD","REDS","LU1003077747.HKD","LU1244550494.USD","PJP","LU1732800096.USD","IE00BDGV0183.EUR","FRHC","GLAM","LU0289961442.SGD","TRUH","LU1236620834.HKD","FTXH","LU1732799900.SGD","MEDX","IPOS","LU0211328371.USD","01477","BK4585","IXJ","FHLC","IE0009355771.USD","JDOC","AGNG","IYH","LU0256863902.USD","XLV","IE0002141913.USD","RXL","BK4550","BK4566","BK4534","BK1574","ABBV","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109790453","title":"艾伯维达成合作，加速免疫学、神经科学与肿瘤学领域小分子药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1109790453","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109790453?lang=zh_cn&edition=full","pubTime":"2026-09-21 20:02","pubTimestamp":1789992130,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布建立一项全新合作伙伴关系，旨在推动免疫学、神经科学以及肿瘤学领域的小分子药物发现进程。这一战略举措，标志着该公司在上述关键治疗领域的研发步伐将显著提速。通过整合外部创新资源与内部研发优势，艾伯维力求缩短药物从实验室走向临床的周期。此举不仅有望丰富其管线储备，也可能为疑难病症的治疗带来突破性方案。在当前医药行业竞争日趋激烈的背景下，此类协同合作愈发凸显其战略价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000MB6IJN5.SGD","LU0868494617.USD","TRUH","LU0912757837.SGD","LU2237443895.HKD","SG9999001440.SGD","BK4588","LU1236620834.HKD","MEDX","ABBV","LU1236620750.USD","LU1670628061.USD","JDOC","IE00B3PB1722.GBP","LU2023251221.USD","LU1718418525.SGD","LU0211328371.USD","LU0203345920.USD","IE00BLSP4452.SGD","PPH","LU0708994859.HKD","LU0942090050.USD","LU2089984988.USD","LU1983299246.USD","LU2087621335.USD","LU2237443549.SGD","BK4566","AGNG","LU0114720955.EUR","SG9999003800.SGD","LU0859254822.USD","IE00BSNM7G36.USD","LU1093756168.USD","LU0234570918.USD","LU1732799900.SGD","IE0004445239.USD","LU0868494708.USD","LU0882574055.USD","LU1585245621.USD","LU0689472784.USD","LU1989772840.SGD","IE00B19Z3581.USD","LU0820561818.USD","IE00BBT3K403.USD","LU0795875169.SGD","LU2125909593.SGD","SG9999015978.USD","LU1061106388.HKD","SG9999015945.SGD","BK4533","LU0511384066.AUD","BK4585","LU0310800379.SGD","LU0861579265.USD","LU2433249047.HKD","LU1670627923.USD","LU2089283258.USD","LU0203347892.USD","LU2129689514.USD","LU0965509101.SGD","LU0985320562.USD","IE000F7OJYX1.SGD","LU2237443622.USD","LU1720051017.SGD","LU1244550221.USD","IXJ","LU1934455194.USD","FTXH","LU0058720904.USD","LU0289961442.SGD","LU0432979614.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU1093756325.SGD","LU0456855351.SGD","LU0738911758.USD","LU2133065610.SGD","LU0689626769.HKD","LU0029864427.USD","LU1732800096.USD","LU0965509283.SGD","LU1057294990.SGD","BK4139","LU0098860793.USD","LU0417517546.SGD","LU1037948897.HKD","GLAM","LU0661504455.SGD","IE00B19Z3B42.SGD","LU1291159041.SGD","LU2357627491.SGD","LU0069063385.USD","LU1162221912.USD","LU2089284900.SGD","IE00BN8TJ469.HKD","LU0256863811.USD","IE0009355771.USD","LU0234572021.USD","LU1929549753.HKD","IE0002141913.USD","LU0256863902.USD","LU0057025933.USD","LU2129689431.USD","IE000BZT7R73.USD","LU0795875086.SGD","IE0000B7K699.USD","LU0965509010.AUD","LU0949170772.SGD","PJP","LU0310799852.SGD","LU2237443382.USD","IE00BVYPNW00.USD","BK4581","LU2112291526.USD","LU0128525929.USD","BK4534","LU2357305700.SGD","LU0943347566.SGD","LU1989771016.USD","LU1267930573.SGD","LU0726765562.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0965508806.USD","LU0395794307.EUR","LU1496350171.SGD","LU1934455863.HKD","LU2129689605.HKD","LU2347655073.USD","LU1551013425.SGD","LU2125909247.SGD","LU1430594728.SGD","IE00BLSP4239.USD","LU0553294199.USD","SG9999015986.USD","LU0122379950.USD","LU1720051108.HKD","IYH","BK4559","IE00BFTCPJ56.SGD","LU1003077747.HKD","LU1839511570.USD","VHT","LU2237443465.HKD","RXL","LU0320765646.SGD","LU1934455277.USD","LU1496350502.SGD","LU2237443978.SGD","LU0823416689.USD","LU1548497426.USD","LU0158827948.USD","LU1023059063.AUD","LU2347655156.SGD","LU0211327993.USD","LU1037948541.HKD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU0124676726.USD","SG9999011175.SGD","BK4550","IE0002270589.USD","LU1267930490.SGD","LU1923622614.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0545039389.USD","LU1551013342.USD","LU1989772923.USD","LU1074936037.SGD","LU0170899867.USD","LU0289739343.SGD","LU1244550494.USD","SG9999015952.SGD","IE000WAW04H5.SGD","IE00BDGV0183.EUR","LU2468319806.SGD","FHLC","IE00B4R5TH58.HKD","LU1244550577.SGD","IE00BJJMRZ35.SGD","LU0198837287.USD","IE00B42XCP33.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126099166","title":"艾伯维与Iambic达成合作：前期付款、里程碑付款及分级版税条款揭晓","url":"https://stock-news.laohu8.com/highlight/detail?id=1126099166","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126099166?lang=zh_cn&edition=full","pubTime":"2026-09-21 20:02","pubTimestamp":1789992127,"startTime":"0","endTime":"0","summary":"艾伯维公司与Iambic生物科技公司达成一项合作协议。根据协议，Iambic将获得一笔前期付款、若干里程碑付款，以及基于合作进展的分级版税收入。Iambic不仅将收到首笔预付款项，还有望在达成特定开发、监管及商业化里程碑时，陆续收获额外资金。同时，分级版税机制也为其长期收益提供了保障。艾伯维作为大型制药企业，显然看中了Iambic在相关领域的研发潜力；而对Iambic而言，这笔交易不仅输血助力，更是验证其技术平台价值的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","IE00BVYPNW00.USD","LU1074936037.SGD","LU1934455863.HKD","LU2125909247.SGD","IE00BBT3K403.USD","AGNG","LU0795875086.SGD","LU2087621335.USD","LU1267930573.SGD","LU0868494708.USD","LU1989771016.USD","IE000F7OJYX1.SGD","LU1093756325.SGD","LU0511384066.AUD","LU2347655156.SGD","LU2237443549.SGD","LU2468319806.SGD","LU1670628061.USD","LU1430594728.SGD","SG9999001440.SGD","BK4581","ABBV","IE0002270589.USD","LU0726765562.USD","LU1720051108.HKD","IE0009355771.USD","LU0289739699.SGD","LU0211328371.USD","LU1037948541.HKD","SG9999015952.SGD","LU0057025933.USD","LU1720051017.SGD","IE000MB6IJN5.SGD","IE00B42XCP33.USD","LU2112291526.USD","JDOC","LU0310799852.SGD","LU2133065610.SGD","IE000BZT7R73.USD","IE00BDGV0183.EUR","BK4588","LU1548497426.USD","LU0882574055.USD","RXL","LU0708994859.HKD","LU1057294990.SGD","LU0256863902.USD","LU0949170772.SGD","LU1732799900.SGD","LU1670627923.USD","LU0170899867.USD","LU1934455277.USD","LU1003077747.HKD","LU0256863811.USD","LU0868494617.USD","LU1923622614.USD","IE00BVYPNV92.GBP","LU2237443382.USD","LU0456855351.SGD","LU0942090050.USD","IE00BJT1NW94.SGD","LU0820561818.USD","LU0098860793.USD","PJP","LU0069063385.USD","LU0058720904.USD","LU2089984988.USD","VHT","LU0823416689.USD","GLAM","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","IE0002141913.USD","LU0203347892.USD","IYH","LU1934455194.USD","LU1093756168.USD","LU1551013425.SGD","IE000SO60NU8.SGD","LU2089284900.SGD","LU2237443978.SGD","LU0234572021.USD","LU0985320562.USD","IE00B19Z3581.USD","LU0861579265.USD","LU1244550221.USD","LU1244550494.USD","LU0965509283.SGD","LU2237443622.USD","LU2237443895.HKD","LU1236620834.HKD","LU0965509010.AUD","LU1732800096.USD","LU2089283258.USD","SG9999015978.USD","LU1162221912.USD","LU0395794307.EUR","LU0417517546.SGD","LU0029864427.USD","LU1718418525.SGD","LU2433249047.HKD","BK4585","BK4139","LU1585245621.USD","LU0820561909.HKD","SG9999011175.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1989772923.USD","IE00BSNM7G36.USD","LU2129689431.USD","SG9999003800.SGD","LU0128525929.USD","LU0122379950.USD","LU1267930490.SGD","LU1236620750.USD","BK4533","LU0738911758.USD","LU0943347566.SGD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU2125909593.SGD","TRUH","LU0859254822.USD","IE00BLSP4452.SGD","LU0198837287.USD","LU0124676726.USD","LU0965509101.SGD","IE0000B7K699.USD","IE00BJJMRZ35.SGD","IE00BLSP4239.USD","FHLC","LU0114720955.EUR","LU1244550577.SGD","LU1989772840.SGD","LU2129689605.HKD","LU0310800379.SGD","LU0965508806.USD","LU0545039389.USD","LU0289739343.SGD","BK4566","BK4559","LU1929549753.HKD","LU1983299246.USD","SG9999015986.USD","LU0689472784.USD","BK4550","LU0472753341.HKD","MEDX","PPH","SG9999015945.SGD","LU0211327993.USD","LU0320765646.SGD","LU2237443465.HKD","LU1496350502.SGD","LU0203345920.USD","LU1291159041.SGD","LU0795875169.SGD","LU2347655073.USD","FTXH","IE000WAW04H5.SGD","LU0289961442.SGD","LU1037948897.HKD","IE00B2B36J28.USD","LU1023059063.AUD","XLV","LU0912757837.SGD","LU1496350171.SGD","LU1839511570.USD","LU0234570918.USD","LU1551013342.USD","IXJ","LU0432979614.USD","LU0689626769.HKD","LU2357305700.SGD","LU2357627491.SGD","LU2023251221.USD","BK4534","IE0004445239.USD","LU2129689514.USD","LU0661504455.SGD","LU0553294199.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145849702","title":"艾伯维高管：受医保报销时间影响，Tavapadon美国上市预计将呈“慢热”态势——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1145849702","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145849702?lang=zh_cn&edition=full","pubTime":"2026-09-15 22:32","pubTimestamp":1789482730,"startTime":"0","endTime":"0","summary":"在最近的一场电话会议中，艾伯维公司高层透露，其帕金森病新药Tavapadon在美国市场的上市进程，恐怕会迎来一场“慢热”开局。这背后的关键推手，正是医疗保险报销的时间节点问题。该高管指出，由于Medicare的报销政策在时间上存在特定安排，Tavapadon的商业化放量节奏或将受到明显牵制。这一预判，无疑为观察者们提供了一个审视美国药品市场准入复杂性的鲜活样本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU0203345920.USD","LU0417517546.SGD","IE0000B7K699.USD","IE00BFTCPJ56.SGD","LU0128525929.USD","LU0170899867.USD","LU0511384066.AUD","LU0545039389.USD","LU0726765562.USD","LU0820561818.USD","LU1057294990.SGD","LU1074936037.SGD","IE000MB6IJN5.SGD","LU0882574055.USD","LU1718418525.SGD","SG9999015978.USD","IE00B3PB1722.GBP","LU0289739343.SGD","IXJ","LU1244550221.USD","LU1929549753.HKD","BK4139","LU0122379950.USD","IE000BZT7R73.USD","IE00BLSP4239.USD","AGNG","BK4581","SG9999015952.SGD","LU1291159041.SGD","LU0965508806.USD","LU0912757837.SGD","LU1934455194.USD","FHLC","LU1839511570.USD","IE00BSNM7G36.USD","LU1732800096.USD","LU0256863902.USD","LU2237443465.HKD","PPH","IE0004445239.USD","LU1989771016.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU1430594728.SGD","LU0289739699.SGD","BK4559","IE0009355771.USD","LU1162221912.USD","LU0320765646.SGD","IE0002141913.USD","LU2112291526.USD","XLV","LU2089984988.USD","LU0949170772.SGD","RXL","IE00BBT3K403.USD","LU1236620750.USD","LU1496350171.SGD","VHT","BK4585","SG9999015986.USD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU1585245621.USD","IE00BN8TJ469.HKD","LU0158827948.USD","LU0211327993.USD","LU0868494708.USD","IYH","BK4588","IE00B2B36J28.USD","LU1267930490.SGD","LU0861579265.USD","IE00BDGV0183.EUR","LU0689472784.USD","PJP","LU0456855351.SGD","LU1003077747.HKD","LU1983299246.USD","LU0868494617.USD","LU0661504455.SGD","LU2347655073.USD","IE0002270589.USD","IE00BLSP4452.SGD","LU0985320562.USD","FTXH","LU0198837287.USD","LU2023251221.USD","LU2468319806.SGD","IE00BVYPNW00.USD","LU0823416689.USD","LU1551013342.USD","LU2129689431.USD","BK4550","LU2129689514.USD","BK4566","LU0553294199.USD","LU0114720955.EUR","LU1670627923.USD","LU1267930573.SGD","IE00BGHQF631.EUR","ABBV","LU1923622614.USD","LU1989772840.SGD","LU0795875086.SGD","LU2237443978.SGD","TRUH","LU1496350502.SGD","LU0289961442.SGD","LU1934455277.USD","LU2089283258.USD","IE000F7OJYX1.SGD","LU2237443549.SGD","IE00B42XCP33.USD","LU1037948897.HKD","LU1732799900.SGD","LU0098860793.USD","SG9999015945.SGD","LU0211328371.USD","BK4533","LU0057025933.USD","IE00B19Z3581.USD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU0124676726.USD","LU0432979614.USD","LU1236620834.HKD","LU0029864427.USD","LU1093756325.SGD","LU2357627491.SGD","IE00B4R5TH58.HKD","LU0738911758.USD","LU2433249047.HKD","LU0820561909.HKD","IE000SO60NU8.SGD","JDOC","LU0310800379.SGD","LU2125909593.SGD","BK4534","IE00BJJMRZ35.SGD","LU0256863811.USD","IE000WAW04H5.SGD","LU1244550494.USD","LU2237443622.USD","IE00BJT1NW94.SGD","LU2347655156.SGD","LU1061106388.HKD","LU0859254822.USD","LU1989772923.USD","LU0234570918.USD","MEDX","LU0203347892.USD","LU0708994859.HKD","SG9999011175.SGD","LU0310799852.SGD","LU2089284900.SGD","LU1023059063.AUD","LU0234572021.USD","LU1934455863.HKD","LU1670628061.USD","LU0069063385.USD","LU2129689605.HKD","LU2133065610.SGD","LU2087621335.USD","LU0965509010.AUD","GLAM","LU0058720904.USD","LU0795875169.SGD","LU1093756168.USD","LU2237443895.HKD","LU1037948541.HKD","LU0943347566.SGD","LU1551013425.SGD","LU2237443382.USD","LU0689626769.HKD","LU0395794307.EUR","LU0472753341.HKD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100769493","title":"艾伯维高管：血癌药物Etentamig晚期数据将于9月下旬在国际骨髓瘤学会会议上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1100769493","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100769493?lang=zh_cn&edition=full","pubTime":"2026-09-15 22:28","pubTimestamp":1789482491,"startTime":"0","endTime":"0","summary":"在近期的一次电话会议中，艾伯维公司高层透露，其备受关注的血癌治疗药物Etentamig的晚期临床数据，已确定将在今年9月下旬的国际骨髓瘤学会会议上正式亮相。\n这一重磅消息，由公司高管在会议期间亲自确认并对外释放。据悉，该药物的关键性试验结果，选择在国际顶级专业学术平台首发，足见其数据的重要性和潜在的行业影响力。此次披露，无疑为血液肿瘤治疗领域投下了一枚深水炸弹，引发业界广泛关注与期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU0203345920.USD","LU0417517546.SGD","IE0000B7K699.USD","IE00BFTCPJ56.SGD","LU0128525929.USD","LU0170899867.USD","LU0511384066.AUD","LU0545039389.USD","LU0726765562.USD","LU0820561818.USD","LU1057294990.SGD","LU1074936037.SGD","IE000MB6IJN5.SGD","LU0882574055.USD","LU1718418525.SGD","SG9999015978.USD","IE00B3PB1722.GBP","LU0289739343.SGD","IXJ","LU1244550221.USD","LU1929549753.HKD","BK4139","LU0122379950.USD","IE000BZT7R73.USD","IE00BLSP4239.USD","AGNG","BK4581","SG9999015952.SGD","LU1291159041.SGD","LU0965508806.USD","LU0912757837.SGD","LU1934455194.USD","FHLC","LU1839511570.USD","IE00BSNM7G36.USD","LU1732800096.USD","LU0256863902.USD","LU2237443465.HKD","PPH","IE0004445239.USD","LU1989771016.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU1430594728.SGD","LU0289739699.SGD","BK4559","IE0009355771.USD","LU1162221912.USD","LU0320765646.SGD","IE0002141913.USD","LU2112291526.USD","XLV","LU2089984988.USD","LU0949170772.SGD","RXL","IE00BBT3K403.USD","LU1236620750.USD","LU1496350171.SGD","VHT","BK4585","SG9999015986.USD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU1585245621.USD","IE00BN8TJ469.HKD","LU0158827948.USD","LU0211327993.USD","LU0868494708.USD","IYH","BK4588","IE00B2B36J28.USD","LU1267930490.SGD","LU0861579265.USD","IE00BDGV0183.EUR","LU0689472784.USD","PJP","LU0456855351.SGD","LU1003077747.HKD","LU1983299246.USD","LU0868494617.USD","LU0661504455.SGD","LU2347655073.USD","IE0002270589.USD","IE00BLSP4452.SGD","LU0985320562.USD","FTXH","LU0198837287.USD","LU2023251221.USD","LU2468319806.SGD","IE00BVYPNW00.USD","LU0823416689.USD","LU1551013342.USD","LU2129689431.USD","BK4550","LU2129689514.USD","BK4566","LU0553294199.USD","LU0114720955.EUR","LU1670627923.USD","LU1267930573.SGD","IE00BGHQF631.EUR","ABBV","LU1923622614.USD","LU1989772840.SGD","LU0795875086.SGD","LU2237443978.SGD","TRUH","LU1496350502.SGD","LU0289961442.SGD","LU1934455277.USD","LU2089283258.USD","IE000F7OJYX1.SGD","LU2237443549.SGD","IE00B42XCP33.USD","LU1037948897.HKD","LU1732799900.SGD","LU0098860793.USD","SG9999015945.SGD","LU0211328371.USD","BK4533","LU0057025933.USD","IE00B19Z3581.USD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU0124676726.USD","LU0432979614.USD","LU1236620834.HKD","LU0029864427.USD","LU1093756325.SGD","LU2357627491.SGD","IE00B4R5TH58.HKD","LU0738911758.USD","LU2433249047.HKD","LU0820561909.HKD","IE000SO60NU8.SGD","JDOC","LU0310800379.SGD","LU2125909593.SGD","BK4534","IE00BJJMRZ35.SGD","LU0256863811.USD","IE000WAW04H5.SGD","LU1244550494.USD","LU2237443622.USD","IE00BJT1NW94.SGD","LU2347655156.SGD","LU1061106388.HKD","LU0859254822.USD","LU1989772923.USD","LU0234570918.USD","MEDX","LU0203347892.USD","LU0708994859.HKD","SG9999011175.SGD","LU0310799852.SGD","LU2089284900.SGD","LU1023059063.AUD","LU0234572021.USD","LU1934455863.HKD","LU1670628061.USD","LU0069063385.USD","LU2129689605.HKD","LU2133065610.SGD","LU2087621335.USD","LU0965509010.AUD","GLAM","LU0058720904.USD","LU0795875169.SGD","LU1093756168.USD","LU2237443895.HKD","LU1037948541.HKD","LU0943347566.SGD","LU1551013425.SGD","LU2237443382.USD","LU0689626769.HKD","LU0395794307.EUR","LU0472753341.HKD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148213172","title":"艾伯维高管透露：今年将启动Apogee的Zumilokibart患者入组，目标2030年初上市——电话会议纪要","url":"https://stock-news.laohu8.com/highlight/detail?id=1148213172","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148213172?lang=zh_cn&edition=full","pubTime":"2026-09-15 22:23","pubTimestamp":1789482194,"startTime":"0","endTime":"0","summary":"在近日召开的一场电话会议中，艾伯维公司高管明确表态，公司计划于今年正式启动针对Apogee旗下药物Zumilokibart的患者入组工作。此举被视为该药物研发进程中的关键一步，标志着其临床试验阶段即将全面铺开。Zumilokibart作为Apogee的核心资产之一，其进展速度与质量，将直接影响公司未来数年的产品组合竞争力。展望未来，随着入组工作的逐步展开，更多关于Zumilokibart的疗效与安全性数据将陆续浮出水面。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","LU1983299246.USD","VHT","SG9999003800.SGD","BK4566","LU0170899867.USD","LU0417517546.SGD","LU1989772923.USD","IE00B3PB1722.GBP","LU1093756325.SGD","PJP","LU0823416689.USD","LU0949170772.SGD","LU0029864427.USD","AGNG","ABBV","IE000WAW04H5.SGD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0128525929.USD","LU1023059063.AUD","LU2112291526.USD","LU1923622614.USD","LU1430594728.SGD","LU1074936037.SGD","LU0211327993.USD","LU0868494617.USD","LU1934455863.HKD","BK4581","LU2237443465.HKD","LU0289739699.SGD","PPH","LU0158827948.USD","LU1551013425.SGD","LU0432979614.USD","LU1037948897.HKD","LU1267930573.SGD","LU2237443622.USD","LU0661504455.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","LU0861579265.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00BGHQF631.EUR","LU1244550577.SGD","LU0289961442.SGD","LU0310799852.SGD","IE0009355771.USD","LU1929549753.HKD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU2023251221.USD","BK4534","IE00BLSP4239.USD","LU1839511570.USD","IE000SO60NU8.SGD","IE000F7OJYX1.SGD","LU2089283258.USD","JDOC","LU1496350502.SGD","IE0004445239.USD","LU0098860793.USD","IE000BZT7R73.USD","LU1551013342.USD","BK4550","LU0124676726.USD","LU0057025933.USD","LU1934455277.USD","LU0058720904.USD","LU2129689431.USD","SG9999015978.USD","LU1236620834.HKD","LU1236620750.USD","LU0310800379.SGD","LU0882574055.USD","LU1003077747.HKD","IE00B19Z3581.USD","LU0820561909.HKD","IYH","BK4559","LU0234572021.USD","LU0795875086.SGD","LU0545039389.USD","BK4588","LU0114720955.EUR","LU0203345920.USD","LU2237443382.USD","LU0965509101.SGD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU0289739343.SGD","XLV","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","IE0000B7K699.USD","LU1496350171.SGD","LU1244550494.USD","LU1732800096.USD","BK4585","LU1093756168.USD","IE0002270589.USD","LU0456855351.SGD","IE00BVYPNV92.GBP","LU1670627923.USD","LU2357627491.SGD","GLAM","LU1934455194.USD","SG9999011175.SGD","LU0912757837.SGD","LU1718418525.SGD","LU0320765646.SGD","LU0553294199.USD","LU2125909593.SGD","LU0965509283.SGD","LU0256863902.USD","LU0203347892.USD","LU0211328371.USD","LU0795875169.SGD","LU0198837287.USD","LU1267930490.SGD","LU2087621335.USD","LU2133065610.SGD","IE00BLSP4452.SGD","FHLC","SG9999015945.SGD","BK4533","LU2089284900.SGD","IXJ","SG9999015952.SGD","LU2129689605.HKD","LU1989772840.SGD","LU1670628061.USD","IE00B42XCP33.USD","LU2433249047.HKD","LU0868494708.USD","LU2347655156.SGD","LU1244550221.USD","LU0708994859.HKD","LU0738911758.USD","LU1061106388.HKD","LU2089984988.USD","LU2237443549.SGD","TRUH","LU0859254822.USD","SG9999015986.USD","LU0395794307.EUR","LU0820561818.USD","RXL","LU2347655073.USD","LU0256863811.USD","FTXH","MEDX","SG9999001440.SGD","LU2237443895.HKD","BK4139","LU1989771016.USD","LU0472753341.HKD","LU1037948541.HKD","IE000MB6IJN5.SGD","LU0943347566.SGD","LU0069063385.USD","LU1732799900.SGD","LU2129689514.USD","LU2237443978.SGD","LU1585245621.USD","IE00BDGV0183.EUR","LU0122379950.USD","LU0689472784.USD","LU0689626769.HKD","LU0942090050.USD","IE0002141913.USD","LU2125909247.SGD","IE00B2B36J28.USD","LU1162221912.USD","LU0985320562.USD","LU0726765562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176903671","title":"艾伯维高管：现有产品组合为未来十年强劲增长提供\"清晰视野\"——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1176903671","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176903671?lang=zh_cn&edition=full","pubTime":"2026-09-15 22:21","pubTimestamp":1789482069,"startTime":"0","endTime":"0","summary":"在最近的一次电话会议中，艾伯维公司高管明确表示，公司目前的产品组合已然构筑起一道通往未来十年超强增长的\"清晰路径\"。这一表态，无疑为市场注入了强劲的信心。据其所述，凭借现有的业务布局与管线储备，公司完全有能力在相当长的时期内维持令人瞩目的发展势头，这不仅是对当下实力的肯定，更是对未来潜力的有力背书。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1732799900.SGD","LU1989772923.USD","SG9999015952.SGD","LU0211327993.USD","LU1023059063.AUD","LU1037948541.HKD","IE000BZT7R73.USD","LU2087621335.USD","LU2347655156.SGD","LU2347655073.USD","BK4566","LU0708994859.HKD","LU2089284900.SGD","LU1989771016.USD","LU1551013425.SGD","LU1989772840.SGD","MEDX","LU0661504455.SGD","LU1934455863.HKD","IE00BVYPNV92.GBP","LU0029864427.USD","LU0965509010.AUD","LU0234572021.USD","BK4550","IE00BFTCPJ56.SGD","LU0942090050.USD","IE00B42XCP33.USD","SG9999003800.SGD","IE000WAW04H5.SGD","LU2237443465.HKD","LU0795875169.SGD","LU0395794307.EUR","LU1244550221.USD","LU0069063385.USD","LU0256863902.USD","LU0310799852.SGD","XLV","LU0058720904.USD","LU0198837287.USD","LU1839511570.USD","RXL","IXJ","AGNG","LU0965508806.USD","TRUH","LU2237443549.SGD","LU0310800379.SGD","LU1037948897.HKD","LU0256863811.USD","BK4139","BK4534","LU2129689431.USD","LU0472753341.HKD","LU0545039389.USD","IE00BLSP4452.SGD","LU0234570918.USD","PPH","LU0738911758.USD","LU0868494708.USD","SG9999001440.SGD","LU1003077747.HKD","LU0868494617.USD","LU1585245621.USD","LU2023251221.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU1057294990.SGD","IE0002141913.USD","LU0417517546.SGD","LU1291159041.SGD","LU2129689514.USD","PJP","SG9999015945.SGD","LU1093756168.USD","LU1267930573.SGD","IE000MB6IJN5.SGD","LU0985320562.USD","LU0820561909.HKD","IE00B4R5TH58.HKD","LU0456855351.SGD","LU0203345920.USD","LU1496350502.SGD","IE0000B7K699.USD","SG9999015986.USD","BK4585","LU1934455277.USD","BK4588","IE00BBT3K403.USD","LU1236620834.HKD","LU1718418525.SGD","LU0203347892.USD","GLAM","IE00B19Z3581.USD","IE00BDGV0183.EUR","LU1496350171.SGD","BK4533","LU0882574055.USD","LU1267930490.SGD","LU2468319806.SGD","VHT","BK4581","LU1670628061.USD","LU0128525929.USD","LU1236620750.USD","LU1430594728.SGD","LU0795875086.SGD","LU0859254822.USD","LU1934455194.USD","LU2237443895.HKD","IE000F7OJYX1.SGD","LU1732800096.USD","ABBV","LU0689472784.USD","LU1929549753.HKD","BK4559","LU0158827948.USD","LU2129689605.HKD","LU0823416689.USD","LU1983299246.USD","JDOC","LU0726765562.USD","LU1074936037.SGD","LU0289961442.SGD","IE00BJT1NW94.SGD","LU1551013342.USD","LU2125909593.SGD","FTXH","LU2357627491.SGD","LU0861579265.USD","LU0965509101.SGD","LU0320765646.SGD","LU0689626769.HKD","LU2125909247.SGD","IE000SO60NU8.SGD","LU0912757837.SGD","LU0432979614.USD","LU0170899867.USD","IE00BSNM7G36.USD","IE00BGHQF631.EUR","LU0114720955.EUR","LU2237443622.USD","LU1162221912.USD","IE00BJJMRZ35.SGD","LU1244550494.USD","LU0943347566.SGD","IE0004445239.USD","IE0009355771.USD","IE00B3PB1722.GBP","LU2433249047.HKD","SG9999011175.SGD","LU1244550577.SGD","LU2089984988.USD","LU2133065610.SGD","IE00BVYPNW00.USD","LU2237443382.USD","LU0289739343.SGD","LU0211328371.USD","IYH","LU0820561818.USD","LU2237443978.SGD","LU0949170772.SGD","IE00BN8TJ469.HKD","LU0098860793.USD","LU1923622614.USD","LU0553294199.USD","LU2089283258.USD","LU0124676726.USD","LU0511384066.AUD","IE00BLSP4239.USD","FHLC","SG9999015978.USD","LU1061106388.HKD","LU2112291526.USD","LU0122379950.USD","LU0057025933.USD","IE0002270589.USD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191303955","title":"艾伯维高管：稳健资产负债表与长期成长空间并存，公司可兼顾早期及晚期业务拓展机会——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1191303955","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191303955?lang=zh_cn&edition=full","pubTime":"2026-09-09 22:56","pubTimestamp":1788965760,"startTime":"0","endTime":"0","summary":"在近日一场备受关注的电话会议中，艾伯维公司高管明确表示，凭借其稳健的资产负债表以及充裕的长期增长跑道，公司目前能够同时审视并把握早期与晚期阶段的业务拓展契机。这一表态暗示，这家制药巨头在战略布局上拥有充分的灵活性与多元选择空间，既可着眼于处于萌芽阶段的创新资产，亦不排除对相对成熟项目的果断介入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","LU1934455194.USD","LU0861579265.USD","LU2089283258.USD","LU0124676726.USD","SG9999001440.SGD","LU0114720955.EUR","SG9999003800.SGD","LU1244550221.USD","SG9999015952.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","LU1267930490.SGD","LU2237443382.USD","IE00BBT3K403.USD","LU2237443622.USD","LU2129689431.USD","LU2089984988.USD","IE00BLSP4239.USD","LU1989772923.USD","BK4559","LU0949170772.SGD","LU2129689605.HKD","BK4550","LU1162221912.USD","IE00B2B36J28.USD","LU0289739343.SGD","LU1670628061.USD","LU1236620834.HKD","LU0965509283.SGD","LU1236620750.USD","LU2129689514.USD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","IXJ","LU0029864427.USD","LU0320765646.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","IYH","LU0128525929.USD","JDOC","LU0098860793.USD","LU0820561818.USD","AGNG","LU0965508806.USD","LU2347655073.USD","LU0726765562.USD","LU1983299246.USD","RXL","LU1989771016.USD","LU0859254822.USD","LU1732800096.USD","LU2237443895.HKD","LU0689472784.USD","IE0002270589.USD","LU1267930573.SGD","LU2087621335.USD","BK4533","IE0009355771.USD","IE00BDGV0183.EUR","SG9999011175.SGD","LU0234572021.USD","IE0000B7K699.USD","LU2468319806.SGD","IE0004445239.USD","FTXH","LU1670627923.USD","LU0545039389.USD","LU0965509101.SGD","LU0942090050.USD","LU0170899867.USD","LU0912757837.SGD","LU0985320562.USD","LU0882574055.USD","LU1037948541.HKD","LU1551013342.USD","IE00B3PB1722.GBP","IE00BVYPNW00.USD","LU1496350171.SGD","LU1430594728.SGD","LU1934455277.USD","LU2125909247.SGD","LU0553294199.USD","LU0417517546.SGD","LU2125909593.SGD","LU0211328371.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU0198837287.USD","LU0689626769.HKD","SG9999015978.USD","LU1585245621.USD","VHT","ABBV","BK4566","IE000F7OJYX1.SGD","LU0256863811.USD","LU0708994859.HKD","LU2112291526.USD","BK4139","LU2433249047.HKD","LU2357627491.SGD","LU0738911758.USD","FHLC","LU1061106388.HKD","LU1291159041.SGD","GLAM","LU1929549753.HKD","LU2133065610.SGD","LU0203347892.USD","LU0158827948.USD","LU0511384066.AUD","LU0943347566.SGD","LU1551013425.SGD","LU1093756325.SGD","IE00BSNM7G36.USD","IE00B42XCP33.USD","LU1839511570.USD","LU1093756168.USD","MEDX","LU1074936037.SGD","PPH","SG9999015945.SGD","IE00BGHQF631.EUR","LU0432979614.USD","LU0820561909.HKD","LU0058720904.USD","LU2237443465.HKD","LU0234570918.USD","XLV","LU0661504455.SGD","LU1732799900.SGD","LU0472753341.HKD","LU2347655156.SGD","IE0002141913.USD","LU1496350502.SGD","IE00B19Z3581.USD","LU0289739699.SGD","IE00BVYPNV92.GBP","PJP","LU2237443549.SGD","LU0211327993.USD","LU0057025933.USD","IE000BZT7R73.USD","LU1244550577.SGD","SG9999015986.USD","TRUH","LU1244550494.USD","LU0203345920.USD","LU1057294990.SGD","LU0868494708.USD","LU0795875086.SGD","LU2023251221.USD","LU1718418525.SGD","LU0289961442.SGD","LU0310800379.SGD","LU2089284900.SGD","LU1989772840.SGD","BK4534","LU0965509010.AUD","LU0395794307.EUR","LU1934455863.HKD","LU2237443978.SGD","LU0456855351.SGD","LU1003077747.HKD","BK4581","BK4585","BK4588","LU0310799852.SGD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE000MB6IJN5.SGD","LU0069063385.USD","LU0256863902.USD","LU1037948897.HKD","LU0795875169.SGD","IE000WAW04H5.SGD","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0403},{"period":"1month","weight":0.0774},{"period":"3month","weight":0.1136},{"period":"6month","weight":0.36},{"period":"1year","weight":0.2528},{"period":"ytd","weight":0.2403}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0383},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.1603},{"period":"ytd","weight":0.1318}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.5,"avgChangeRate":0.011241},{"month":8,"riseRate":0.571429,"avgChangeRate":0.008439},{"month":9,"riseRate":0.571429,"avgChangeRate":0.015314},{"month":10,"riseRate":0.642857,"avgChangeRate":0.012862},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}